A detailed history of Parkside Financial Bank & Trust transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Parkside Financial Bank & Trust holds 1,010 shares of CRL stock, worth $188,152. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,010
Previous 984 2.64%
Holding current value
$188,152
Previous $203,000 2.46%
% of portfolio
0.03%
Previous 0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$187.96 - $245.29 $4,886 - $6,377
26 Added 2.64%
1,010 $198,000
Q2 2024

Aug 05, 2024

SELL
$206.39 - $268.73 $12,177 - $15,855
-59 Reduced 5.66%
984 $203,000
Q1 2024

May 01, 2024

BUY
$203.52 - $273.43 $33,377 - $44,842
164 Added 18.66%
1,043 $282,000
Q4 2023

Feb 01, 2024

BUY
$164.52 - $238.84 $19,413 - $28,183
118 Added 15.51%
879 $207,000
Q3 2023

Nov 13, 2023

BUY
$194.44 - $217.61 $14,388 - $16,103
74 Added 10.77%
761 $149,000
Q2 2023

Aug 15, 2023

SELL
$183.71 - $210.25 $8,266 - $9,461
-45 Reduced 6.15%
687 $144,000
Q1 2023

May 04, 2023

BUY
$191.89 - $259.92 $18,421 - $24,952
96 Added 15.09%
732 $147,000
Q4 2022

Feb 13, 2023

BUY
$197.11 - $250.07 $7,490 - $9,502
38 Added 6.35%
636 $138,000
Q3 2022

Nov 01, 2022

BUY
$182.44 - $250.54 $26,271 - $36,077
144 Added 31.72%
598 $118,000
Q2 2022

Jul 13, 2022

SELL
$204.13 - $302.4 $3,061 - $4,536
-15 Reduced 3.2%
454 $98,000
Q1 2022

May 13, 2022

BUY
$255.51 - $362.11 $20,440 - $28,968
80 Added 20.57%
469 $133,000
Q4 2021

Feb 14, 2022

SELL
$351.38 - $448.68 $8,433 - $10,768
-24 Reduced 5.81%
389 $147,000
Q3 2021

Oct 29, 2021

BUY
$372.64 - $458.3 $4,099 - $5,041
11 Added 2.74%
413 $171,000
Q2 2021

Aug 06, 2021

BUY
$294.17 - $371.65 $7,354 - $9,291
25 Added 6.63%
402 $149,000
Q1 2021

May 10, 2021

BUY
$249.67 - $299.48 $94,125 - $112,903
377 New
377 $109,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.48B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Parkside Financial Bank & Trust Portfolio

Follow Parkside Financial Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkside Financial Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Parkside Financial Bank & Trust with notifications on news.